In a report released today, Matt Larew from William Blair maintained a Hold rating on Maravai Lifesciences Holdings (MRVI – Research Report).
The new fund will invest in a niche subset of emerging markets that are 'more challenging for investors to access' ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback